GTC
ASMB icon

Ghost Tree Capital’s Assembly Biosciences ASMB Stock Holding History

Ghost Tree Capital’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-27,083
Closed -$12.1M – 46
2018
Q3 		$12.1M Buy
27,083
+7,500
+38% +$3.51M 2.57% 13
2018
Q2 		$9.21M Buy
19,583
+7,083
+57% +$3.75M 2.71% 12
2018
Q1 		$7.37M Buy
+12,500
New +$7.75M 1.49% 23
2015
Q3 		– Sell
-14,583
Closed -$3.37M – 79
2015
Q2 		$3.37M Buy
14,583
+4,166
+40% +$804K 1.09% 40
2015
Q1 		$1.66M Buy
10,417
+5,000
+92% +$676K 0.6% 59
2014
Q4 		$511K Hold
5,417
– – 0.25% 58
2014
Q3 		$532K Buy
5,417
+2,084
+63% +$185K 0.29% 64
2014
Q2 		$262K Buy
+3,333
New +$236K 0.18% 52

Other funds holding ASMB

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Ghost Tree Capital's ASMB Position: Q4 2018 in Review

Ghost Tree Capital sold out of Assembly Biosciences (ASMB) in Q4 2018, closing a stake of 27,083 shares — an estimated $12.1M sold.

Ghost Tree Capital first reported a position in ASMB in Q2 2014 and held it in 8 quarters. The position peaked at $12.1M in Q3 2018. 106 funds tracked by Wall St. Rank hold ASMB as of Q4 2018.

  • Ghost Tree Capital reported no remaining Assembly Biosciences position as of Q4 2018 after selling out during the quarter.
  • Ghost Tree Capital sold 27,083 Assembly Biosciences shares in Q4 2018, an estimated $12.1M.
  • Ghost Tree Capital first reported a position in Assembly Biosciences in Q2 2014 and held it in 8 quarters.
  • Ghost Tree Capital's Assembly Biosciences position peaked at $12.1M in Q3 2018.
  • 106 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2018.

Based on Ghost Tree Capital's 13F filing for Q4 2018, filed 14 Feb 2019.